Search - tctmd.com

Displaying 421 - 440 of 618

Sort: Relevancy | Date

Presentation NY Valves 2024

Introduction to the Redo TAVR App: Comprehensive Diagnosis and Procedure Planning

Presenter: Vinayak N. Bapat

June 06, 2024

Presentation NY Valves 2024

Mind Your Stent: Managing Ostial Right Coronary Artery Stent Protrusion Before TAVR

Presenter: Ahmed Hassanin

June 06, 2024

Presentation NY Valves 2024

Ping-Pong Technique to Avoid Left Main Occlusion During TAVI

Presenter: Vincenzo Cesario

June 06, 2024

Presentation NY Valves 2024

In younger patients receiving TAVR: why does the first intervention matter?

Presenter: Vinod H. Thourani

June 06, 2024

Presentation NY Valves 2024

Mid-term outcomes of balloon expandable TAVR: do gradients and gender matter?

Presenter: Rebecca T. Hahn

June 06, 2024

Presentation NY Valves 2024

What would a patient consider a good outcome of intervention for symptomatic severe aortic stenosis

Presenter: David J. Cohen

June 06, 2024

Presentation NY Valves 2024

Which endpoints and definitions matter for assessment of bioprosthetic valve durability following TAVR?

Presenter: Philippe Pibarot

June 06, 2024

Presentation NY Valves 2024

Tips and Tricks for TAVR Explantation

Presenter: Vinayak N. Bapat

June 06, 2024

Presentation NY Valves 2024

SAVR After TAVR: A Dangerous Epidemic?

Presenter: Shinichi Fukuhara

June 06, 2024

Presentation NY Valves 2024

Redo TAVR Through Embolized Evolut FX Valve

Presenter: Richard Tanner

June 06, 2024

Presentation NY Valves 2024

TAVR-in-TAVR for an Early Degenerated Bio-Prosthesis

Presenter: Vivek Patel

June 06, 2024

Presentation NY Valves 2024

What is the Status of Valve-in-Valve TAVR in a Bioprosthesis?

Presenter: Gilbert H. L. Tang

June 06, 2024

Presentation NY Valves 2024

Redo TAVR in a Young Patient With Congenital AV Disease

Presenter: Richard Tanner

June 06, 2024

Presentation NY Valves 2024

CT Planning With Redo TAV App Guiding Strategy to Prevent Coronary Obstruction for TAV-in-TAV Procedure

Presenter: Supawat Ratanapo

June 06, 2024

Presentation NY Valves 2024

You are Both Wrong, Engineers Hold the Key to Our Future and the Best Valve Design is Yet to be Found

Presenter: Ajit P. Yoganathan

June 06, 2024

Presentation NY Valves 2024

TAV-in-TAV With a 23mm SAPIEN3 Ultra Resilia in a Degenerated 23mm SAPIEN3 Valve

Presenter: Supawat Ratanapo

June 06, 2024

Presentation NY Valves 2024

SAVR Will Have a Longer Lasting Durability Than TAVR

Presenter: Stephan Windecker

June 06, 2024

Presentation NY Valves 2024

J-Valve

Presenter: Santiago Garcia

June 06, 2024

Presentation NY Valves 2024

Determinants of Intervention Type and All-Cause Mortality of TAVR and SAVR Patients Younger Than 75 Years in the Netherlands

Presenter: Nicolas M. Van Mieghem

June 06, 2024

Presentation NY Valves 2024

TAVR Will Have a Longer Lasting Durability Than SAVR

Presenter: Michael J. Reardon

June 06, 2024

Advertisement

Introduction to the Redo TAVR App: Comprehensive Diagnosis and Procedure Planning

Mind Your Stent: Managing Ostial Right Coronary Artery Stent Protrusion Before TAVR

Ping-Pong Technique to Avoid Left Main Occlusion During TAVI

In younger patients receiving TAVR: why does the first intervention matter?

Mid-term outcomes of balloon expandable TAVR: do gradients and gender matter?

What would a patient consider a good outcome of intervention for symptomatic severe aortic stenosis

Which endpoints and definitions matter for assessment of bioprosthetic valve durability following TAVR?

Tips and Tricks for TAVR Explantation

SAVR After TAVR: A Dangerous Epidemic?

Redo TAVR Through Embolized Evolut FX Valve

TAVR-in-TAVR for an Early Degenerated Bio-Prosthesis

What is the Status of Valve-in-Valve TAVR in a Bioprosthesis?

Redo TAVR in a Young Patient With Congenital AV Disease

CT Planning With Redo TAV App Guiding Strategy to Prevent Coronary Obstruction for TAV-in-TAV Procedure

You are Both Wrong, Engineers Hold the Key to Our Future and the Best Valve Design is Yet to be Found

TAV-in-TAV With a 23mm SAPIEN3 Ultra Resilia in a Degenerated 23mm SAPIEN3 Valve

SAVR Will Have a Longer Lasting Durability Than TAVR

J-Valve

Determinants of Intervention Type and All-Cause Mortality of TAVR and SAVR Patients Younger Than 75 Years in the Netherlands

TAVR Will Have a Longer Lasting Durability Than SAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content